Eli Lilly’s Weight-Loss Pill Foundayo Approved in the UK

Eli Lilly's weight-loss pill, Foundayo, has been granted approval in the United Kingdom, marking it as the second GLP-1 oral medication to receive such clearance in the country. This follows the approval of Novo Nordisk's Wegovy pill, intensifying the competition between the two pharmaceutical companies.

The win for Eli Lilly is part of a broader strategy to extend its weight-loss medication offerings globally, following previous successes in the U.S. market. This development allows Eli Lilly to enter the UK market, expanding the reach of its weight-loss solutions.